Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cipla Ltd ( (IN:CIPLA) ) has provided an update.
Cipla Limited has disclosed that an inspection and search conducted by the Maharashtra Goods & Service Tax Department under Section 67 of the Maharashtra GST Act, 2017, has been concluded as of 7 February 2026. The company stated it has provided all requested documents and clarifications to the authorities, no official document has been issued following the inspection, and there is no material impact on its financials, operations or other activities arising from this regulatory action, indicating limited immediate risk for investors and other stakeholders.
More about Cipla Ltd
Cipla Limited is a leading Indian pharmaceutical company headquartered in Mumbai, operating in the healthcare and life sciences industry. It focuses on the development, manufacturing and distribution of generic medicines and active pharmaceutical ingredients across multiple therapeutic areas, serving domestic and international markets.
Average Trading Volume: 113,044
Technical Sentiment Signal: Hold
Current Market Cap: 1075B INR
For a thorough assessment of CIPLA stock, go to TipRanks’ Stock Analysis page.